On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Pai Life Sciences Inc.'s own share of each project, not the project's full budget.
- Horizon 2020€387k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- VASAPartner
Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa
Horizon 2020 · 2019–2026 · Project on CORDIS ↗
€387ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
- Eberhard Karls Universitaet TuebingenGermany · 1 shared project
- Academisch Ziekenhuis LeidenNetherlands · 1 shared project
- Goeteborgs UniversitetSweden · 1 shared project
- International Vaccine InstituteSouth Korea · 1 shared project
- Groupe de Recherche Action en Sante SARLBurkina Faso · 1 shared project
- University of AntananarivoMadagascar · 1 shared project
- Universite Joseph Ki-ZerboBurkina Faso · 1 shared project
- Texas Tech University SystemUnited States · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- pathology
- tropical medicine
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.